Tag Archives: patents

Time For Myriad To Fight Another Day

Posted on February 4, 2013 by Warren Woessner

Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments

USPTO Publishes Final Rules for Micro-Entity Status and Fee Schedule

Posted on January 17, 2013 by Warren Woessner

On December 19, 2012, the Patent Office published the final rule: “Changes to Implement Micro Entity Status for Paying Patents Fees” –77 Fed. Reg. 75019–and on January 18, 2013 the final fee schedule is expected to be published (link below). … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , | 1 Comment

Supreme Court Denies Cert. in Sherley v. Sebelius

Posted on January 9, 2013 by Warren Woessner

The pesky worry about a possible Supreme Court review of the ruling by the D.C. Court of Appeals affirming the Circuit Court’s dismissal of a challenge to the 2009 NIH Stem Cell Funding Guidelines – which permitted NIH funding of … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , , , | Leave a comment

In re Rosuvastatin Calcium Patent Litigation – Making “Therasense” out of Confusion

Posted on December 20, 2012 by Warren Woessner

Recently, a divided three judge panel sorting out a multi-party Hatch-Waxman suit, ruled that the patentee, Shinonogi, had not committed inequitable conduct in obtaining the patent that was subsequently reissued so as to obtain narrow claims focused on Rosuvastatin, or … Continue reading →

Posted in Inequitable Conduct/Rule 56, Reissue | Tagged , , , , , , , , , , , , , , , , | 1 Comment